Arnold A. Pinkston Joins Beckman Coulter as Senior Vice President, General Counsel and Secretary
FULLERTON, Calif. – Beckman Coulter, Inc. (NYSE:BEC) announced today that Arnold A. Pinkston has been named senior vice president, general counsel effective November 15, 2005, and secretary, effective December 1, 2005 pending Board approval. Pinkston succeeds William H. May who is retiring after 30 years of service as general counsel and an officer of the company. In this role, Pinkston will be responsible for all aspects of legal affairs related to Beckman Coulter and its products on a worldwide basis, and will serve as the corporate secretary. Pinkston started his career in 1984 with the Orrick, Herrington and Sutcliffe law firm in San Francisco. In 1990, Pinkston left to join McKesson Corporation. While at McKesson, he was appointed general counsel of the PCS Health Systems business, which was eventually sold to Eli Lilly Corporation. Pinkston has been with Eli Lilly since 1999 and most recently served as deputy general counsel with responsibilities for the legal affairs of Lilly USA, Lilly’s global pharmaceutical products component and its global marketing and sales organization. “Arnold is an outstanding addition to Beckman Coulter’s senior management,” said Scott Garrett, president and chief executive officer for Beckman Coulter. “He is a well respected, knowledgeable lawyer with deep experience in the healthcare industry. His leadership will take our highly-capable legal department to a higher level of performance.” Pinkston received a bachelor’s degree in geophysics from Yale College and a juris doctor degree from Yale Law School. He currently serves on the Board of Directors of St. Vincent Health and the Board of Directors of the Southwest Autism Research Center. Beckman Coulter, Inc. is a leading manufacturer of biomedical testing instrument systems, tests and supplies that simplify and automate laboratory processes. Spanning the biomedical testing continuum – from pioneering medical research and clinical trials to laboratory diagnostics and point-of- care testing – Beckman Coulter’s 200,000 installed systems provide essential biomedical information to enhance health care around the world. The company, based in Fullerton, Calif., reported 2004 annual sales of $2.4 billion with 64 percent of this amount generated by recurring revenue from supplies, test kits and services. For more information, visit www.beckmancoulter.com.